Advisory Board and Editors Infectious Diseases
Altijana Hromić-Jahjefendić
Dr. Altijana Hromić-Jahjefendić is an associate professor at the Genetics and Bioengineering Department at International University of Sarajevo, Bosnia and Herzegovina. She obtained her bachelor's degree in chemistry and master's degree in Biochemistry and Molecular Biomedicine at Graz University of Technology, Austria. After that she worked for Austrian Center of Industrial Biotechnology and continued to pursue her PhD degree in Biochemistry and Molecular Biomedicine with the focus on Structural biology. Since 2018. she works as professor at International University of Sarajevo at the Genetics and Bioengineering Department. She authored many scientific publications with international colleagues in the field of COVID-19 and cancer research.
Lei Huang
Dr. Lei Huang is a cancer epidemiologist, translational oncologist, digestive surgeon, surgical oncologist, and gastroenterologist. He has published about 50 papers in SCI(E)-indexed journals including Gut, Annals of Surgery, BMC Medicine, JAMA Surgery, Clinical Cancer Research, Cancer Immunology Research, International Journal of Cancer, EBioMedicine, and Gastric Cancer. His works have been cited for about 1000 times.
Dr. Huang has served on the editorial board of Frontiers in Oncology, World Journal of Gastrointestinal Oncology, PeerJ, Medicine, and Translational Cancer Research, and Frontiers in Surgery. He has been peer reviewer for about 50 SCI(E)-indexed journals including Annals of Internal Medicine, Annals of Surgery, Clinical Cancer Research, Journal of the National Comprehensive Cancer Network-JNCCN, Cancer Letters, Oncoimmunology, and Oncologist. He was selected as Best Reviewer for Annals of Internal Medicine twice in 2017 and 2019.
Dr. Huang has been invited to give oral presentations in the ASCO Annual Meeting and International Gastric Cancer Congress (IGCC), and has received Merit Awards in the ESMO Annual Meeting and Awards for Young Investigators in the IGCC.
His research interests majorly cover the epidemiological, clinical, and translational aspects of digestive cancers. He has successfully coordinated several large international investigations with participants from the US and about 20 European countries.
Christine Josenhans
Christine Josenhans is Professor for Microbiology and Medical Microbiology at Max von Pettenkofer Institute of Ludwig Maximilians University Munich and an infectious disease specialist. Until 2017, she was Associate Professor at Hannover Medical School, Germany, also in the field of infection research and molecular and cellular microbiology. Her research foci are on infectious disease agents in general, with specialization in microbiology, biochemistry, immunology, and host-pathogen interactions. She performed her Post-doctoral studies on Yersinia host-pathogen interactions, more specifically on their type III secretion system pore proteins. Current research foci are in persistent bacterial and viral infections, host-pathogen crosstalk and immune interference, as well as in the causal link between infections and cancer.
She is on the board of several undergraduate and graduate teaching programs.
Nancy P. Keller
Professor of Medical Microbiology and Immunology/Bacteriology at the University of Wisconsin, Editor of Fungal Biology and Genetics, American Phytopathological Society Fellow and American Academy of Microbiology Fellow
Kathleen A Kelly
Kathleen Kelly is a Professor who joined the Department of Pathlogy and Lab Medicine in 1999. Dr. Kelly earned her B.S. in Medical Technology and PhD in Immunology at the Ohio State University in Columbus, Ohio. She was a postdoctoral fellow at Washington University in St. Louis, where she worked on the role of T cell subsets in germinal center formation. She then served as a junior faculty member in the Department of Microbiology and Immunology at the University of Arkansas for Medical Sciences. She focused on mucosal immunology and concentrated her studies on immune responses in the reproductive tract.
Dr. Kelly is actively involved in graduate, undergraduate and medical student education. She is a recipient of the Young Scientist Award and past chair of the Immunology Division for the American Society of Microbiology.
Hossein Khiabanian
Hossein is an Associate Professor of Pathology in the Division of Medical Informatics at Rutgers Cancer Institute of New Jersey. His group develops novel analytical methods to understand the underlying genetics of human diseases and the molecular epidemiology of disease-causing organisms using high-throughput genomic data. The group is especially interested in studying tumor clonal evolution, and identifying prognostic markers in cancer, particularly in hematological malignancies. Hossein received his Ph.D. in Physics from Brown University, where he studied galaxy clusters and dark matter structures, using weak gravitational lensing. Prior to joining Rutgers, he was a member of the faculty in the Department Biomedical Informatics at Columbia University.
Judith Klumperman
Professor of Cell Biology, Chair of the Cell Biology Department University Medical Center (UMC) Utrecht, Head of the Cell Microscopy Center (CMC) of the UMC Utrecht.
Editorial boards of: Traffic, Histochemistry and Cell Biology, Biology of the Cell, Molecul
Leondios G Kostrikis
Professor Leondios Kostrikis is a Professor at University of Cyprus. He received his B.Sc. and Ph.D. degrees from New York University and his post-doctoral training at the Aaron Diamond AIDS Research Center of Rockefeller University. He joined the Rockefeller University as an Assistant Professor in 1999 and the University of Cyprus as Professor in 2003. He was a Fulbright, Elizabeth Glazer Pediatric AIDS Foundation and Aaron Diamond Foundation scholar. He has directed over twenty competitive grants from the NIH and the European Commission and he is an Editorial Board member for eleven international journals.
Theerapong Krajaejun
Professor of Clinical Pathology, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Corinne I. Lasmezas
Corinne Lasmézas, DVM, Ph.D. serves as a Professor at The Scripps Research Institute. Since Dr. Lasmézas' appointment at Scripps in 2005, she has focused on how misfolded proteins lead to neuronal dysfunction and loss in diseases including Alzheimer’s, Parkinson’s and prion diseases. Additionally, Dr. Lasmézas is a reviewer for national and private funding agencies worldwide, including the US National Institutes of Health (NIH) and the UK Medical Research Council and an Advisor for the US Food and Drug Administration (FDA), the US Environmental Protection Agency (EPA) and the US Department of Agriculture (USDA). Earlier in her career, Dr. Lasmézas’ research provided the first experimental evidence that the prion disease “mad cow disease” had been transmitted to humans, causing variant Creutzfeldt-Jakob disease. At the peak of the mad cow crisis, Dr. Lasmézas became an advisor to the World Health Organization (WHO) as well as several governmental and public health committees. She is multiple TED speaker and is an internationally recognized expert in the field of neurodegenerative diseases. She has published more than 60 original scientific papers. She has been a Member of Scientific Advisory Board at Anavex Life Sciences Corp. since March 2015. Dr. Lasmézas holds a PhD in Neurosciences from the University Pierre & Marie Curie in Paris and obtained her Doctorate of Veterinary Medicine and Diploma of Aeronautic and Space Medicine from the University of Toulouse, France.
Claudio R. Lazzari
Professor at the University of Tours and researcher at the Institut de Recherche sur la Biologie de l'Insecte. Interested on the study of the behavioural physiology of insects, in particular disease vectors, using an integrative approach. orcid.org/0000-0003-3703-0302
Sunhee Lee
Dr. Sunhee Lee received her Ph.D. from the University of Arizona, where she worked in the laboratory of Dr. Christina Kennedy. Her graduate studies and research were focused on the area of plant-microbe interactions. After completing her graduate studies, Dr. Lee trained as a postdoctoral fellow in Dr. William Jacobs's laboratory at the Albert Einstein College of Medicine. In Dr. Jacob's laboratory, she researched the pathogenicity and immune responses of Mycobacterium tuberculosis and generated and tested live TB vaccine candidates that had been genetically engineered. Dr. Lee moved to Duke University as an Assistant Professor at the Human Vaccine Institute and Department of Molecular Genetics and Microbiology. As an investigator at Duke University, she continued to expand the research field to other host-mycobacterial interactions and their impact on immunogenicity and pathogenicity. Additionally, Dr. Lee's laboratory developed recombinant mycobacteria capable of eliciting strong HIV/SIV-specific immune responses. Currently, Dr. Lee is an Associate professor at the University of Texas Medical Branch, where she has been working to discover and develop new therapeutics and vaccines against M. tuberculosis and nontuberculous mycobacteria.